Literature DB >> 31012869

Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Justin A Fletcher1, Stanisław Deja1,2, Santhosh Satapati3,4, Xiaorong Fu1, Shawn C Burgess1,3, Jeffrey D Browning4,5,6.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, and potentially morbid, disease that affects one-third of the U.S. population. Normal liver safely accommodates lipid excess during fasting or carbohydrate restriction by increasing their oxidation to acetyl-CoA and ketones, yet lipid excess during NAFLD leads to hyperglycemia and, in some, steatohepatitis. To examine potential mechanisms, flux through pathways of hepatic oxidative metabolism and gluconeogenesis were studied using five simultaneous stable isotope tracers in ketotic (24-hour fast) individuals with a wide range of hepatic triglyceride contents (0-52%). Ketogenesis was progressively impaired as hepatic steatosis and glycemia worsened. Conversely, the alternative pathway for acetyl-CoA metabolism, oxidation in the tricarboxylic (TCA) cycle, was upregulated in NAFLD as ketone production diminished and positively correlated with rates of gluconeogenesis and plasma glucose concentrations. Increased respiration and energy generation that occurred in liver when β-oxidation and TCA cycle activity were coupled may explain these findings, inasmuch as oxygen consumption was higher during fatty liver and highly correlated with gluconeogenesis. These findings demonstrate that increased glucose production and hyperglycemia in NAFLD is not a consequence of acetyl-CoA production per se, but how acetyl-CoA is further metabolized in liver.

Entities:  

Keywords:  Gluconeogenesis; Glucose metabolism; Hepatology; Metabolism; Mitochondria

Year:  2019        PMID: 31012869      PMCID: PMC6629163          DOI: 10.1172/jci.insight.127737

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  78 in total

1.  An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans.

Authors:  J G Jones; M A Solomon; S M Cole; A D Sherry; C R Malloy
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-10       Impact factor: 4.310

2.  Analysis of gluconeogenic pathways in vivo by distribution of 2H in plasma glucose: comparison of nuclear magnetic resonance and mass spectrometry.

Authors:  Shawn C Burgess; Merrill Nuss; Visvanathan Chandramouli; Dana S Hardin; Mark Rice; Bernard R Landau; Craig R Malloy; A Dean Sherry
Journal:  Anal Biochem       Date:  2003-07-15       Impact factor: 3.365

3.  PYRUVATE CARBOXYLASE. I. NATURE OF THE REACTION.

Authors:  M F UTTER; D B KEECH
Journal:  J Biol Chem       Date:  1963-08       Impact factor: 5.157

4.  D-beta-Hydroxybutyric dehydrogenase of muitochondria.

Authors:  A L LEHNINGER; H C SUDDUTH; J B WISE
Journal:  J Biol Chem       Date:  1960-08       Impact factor: 5.157

Review 5.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

Authors:  P J Randle
Journal:  Diabetes Metab Rev       Date:  1998-12

6.  Functional expression, purification, and characterization of recombinant human pyruvate carboxylase.

Authors:  S Jitrapakdee; M E Walker; J C Wallace
Journal:  Biochem Biophys Res Commun       Date:  1999-12-20       Impact factor: 3.575

7.  Splanchnic glucose and amino acid metabolism in obesity.

Authors:  P Felig; J Wahren; R Hendler; T Brundin
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

8.  Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism.

Authors:  Madelon M Buijs; Jacobus Burggraaf; Carla Wijbrandts; Marieke L de Kam; Marijke Frölich; Adam F Cohen; Johannes A Romijn; Hans P Sauerwein; A Edo Meinders; Hanno Pijl
Journal:  Am J Clin Nutr       Date:  2003-03       Impact factor: 7.045

9.  Noninvasive evaluation of liver metabolism by 2H and 13C NMR isotopomer analysis of human urine.

Authors:  Shawn C Burgess; Brian Weis; John G Jones; Erin Smith; Matthew E Merritt; David Margolis; A Dean Sherry; Craig R Malloy
Journal:  Anal Biochem       Date:  2003-01-15       Impact factor: 3.365

10.  Resistance to ketosis in moderately obese patients: influence of fatty liver.

Authors:  T Inokuchi; M Orita; K Imamura; T Takao; S Isogai
Journal:  Intern Med       Date:  1992-08       Impact factor: 1.271

View more
  40 in total

1.  INCA 2.0: A tool for integrated, dynamic modeling of NMR- and MS-based isotopomer measurements and rigorous metabolic flux analysis.

Authors:  Mohsin Rahim; Mukundan Ragavan; Stanislaw Deja; Matthew E Merritt; Shawn C Burgess; Jamey D Young
Journal:  Metab Eng       Date:  2021-12-26       Impact factor: 9.783

2.  Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.

Authors:  Muhammed S Muyyarikkandy; Marc McLeod; Meghan Maguire; Rohit Mahar; Nathan Kattapuram; Christine Zhang; Chaitra Surugihalli; Vaishna Muralidaran; Kruthi Vavilikolanu; Clayton E Mathews; Matthew E Merritt; Nishanth E Sunny
Journal:  FASEB J       Date:  2020-09-12       Impact factor: 5.191

Review 3.  Exercise Combats Hepatic Steatosis: Potential Mechanisms and Clinical Implications.

Authors:  John P Thyfault; R Scott Rector
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

4.  β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.

Authors:  Jacob T Mey; Melissa L Erickson; Christopher L Axelrod; William T King; Chris A Flask; Arthur J McCullough; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-12       Impact factor: 4.310

Review 5.  Tracking the carbons supplying gluconeogenesis.

Authors:  Ankit M Shah; Fredric E Wondisford
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

Review 6.  A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD.

Authors:  Mary P Moore; Rory P Cunningham; Ryan J Dashek; Justine M Mucinski; R Scott Rector
Journal:  Obesity (Silver Spring)       Date:  2020-09-06       Impact factor: 5.002

7.  Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD Model.

Authors:  Pavla Staňková; Otto Kučera; Eva Peterová; Moustafa Elkalaf; David Rychtrmoc; Jan Melek; Miroslav Podhola; Veronika Zubáňová; Zuzana Červinková
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

Review 8.  In vivo2H/13C flux analysis in metabolism research.

Authors:  Tomasz K Bednarski; Mohsin Rahim; Jamey D Young
Journal:  Curr Opin Biotechnol       Date:  2021-05-25       Impact factor: 10.279

Review 9.  Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?

Authors:  Agostino Di Ciaula; Salvatore Passarella; Harshitha Shanmugam; Marica Noviello; Leonilde Bonfrate; David Q-H Wang; Piero Portincasa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 10.  Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ignazio Grattagliano; Agostino Di Ciaula; Jacek Baj; Emilio Molina-Molina; Harshitha Shanmugam; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.